BTIG analyst Ryan Zimmerman downgraded Integra LifeSciences (NASDAQ: IART) from Neutral to Sell with a price target of $22.00.The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades

Form 10-Q INTEGRA LIFESCIENCES For: Jun 30July 29, 2024 4:08 PM Integra LifeSciences (IART) call put ratio 3.1 calls to 1 put as share price down 18.7%July 29, 2024 3:24 PM Form 8-K INTEGRA LIFESCIENCES For: Jul 29July 29, 2024 6:16 AM Integra LifeSciences (IART) Tops Q2 EPS by 1cJuly 29, 2024 6:05 AM Integra LifeSciences Reports Second Quarter 2024 Financial ResultsJuly 29, 2024 6:00 AM